Literature DB >> 11191939

Protective effect of unstable angina in coronary artery bypass surgery.

Z K Wu1, E Pehkonen, J Laurikka, L Kaukinen, E L Honkonen, S Kaukinen, M R Tarkka.   

Abstract

OBJECTIVE: To test the hypothesis that recent ischaemic episodes in unstable cases have a protective effect on coronary artery bypass graft (CABG) patients.
MATERIALS AND METHODS: Twenty unstable patients with ischaemic episodes within 3 days before operation were compared with 20 stable patients. Haemodynamic data were monitored up to the first postoperative day. Biochemical markers were measured up to the second postoperative day.
RESULTS: The cardiac index decreased at 1 and 6 h after declamping in the stable group (89% and 97% of baseline) but increased in unstable patients (104% and 122%, p =0.038 and 0.036, respectively). The depression in the right ventricular stroke work index was significantly attenuated in the unstable group (58%, 67% and 83% in stable and 90%, 97% and 117% in unstable patients, p = 0.027, 0.010 and 0.049 at 1 and 6 h after declamping and 1st POD). The release of cardiac troponin I (CTnI) and CK-MB was significantly lower in the unstable group at 6 h after declamping (5.6 +/- 2.9 and 19.0 +/- 6.3 microg/l in unstable vs 17.4 +/- 9.6 and 25.8 +/- 12.3 microg/l in stable patients, p = 0.000 and 0.039, respectively).
CONCLUSION: Recent unstable angina before CABG might act as an ischaemic preconditioning stimulus and could improve haemodynamic function and cellular viability. Delayed preconditioning most likely causes this protective effect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11191939     DOI: 10.1080/140174300750064657

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  1 in total

1.  Q10 supplementation effects on cardiac enzyme CK-MB and troponin in patients undergoing coronary artery bypass graft: a randomized, double-blinded, placebo-controlled clinical trial.

Authors:  Jalal Moludi; Seyedali Keshavarz; Ali Sadeghpour Tabaee; Saeid Safiri; Reza Pakzad
Journal:  J Cardiovasc Thorac Res       Date:  2016-03-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.